171 related articles for article (PubMed ID: 24831994)
1. The impact of Fourier-Domain optical coherence tomography catheter induced motion artefacts on quantitative measurements of a PLLA-based bioresorbable scaffold.
van Ditzhuijzen NS; Karanasos A; Bruining N; van den Heuvel M; Sorop O; Ligthart J; Witberg K; Garcia-Garcia HM; Zijlstra F; Duncker DJ; van Beusekom HM; Regar E
Int J Cardiovasc Imaging; 2014 Aug; 30(6):1013-26. PubMed ID: 24831994
[TBL] [Abstract][Full Text] [Related]
2. Interstudy reproducibility of the second generation, Fourier domain optical coherence tomography in patients with coronary artery disease and comparison with intravascular ultrasound: a study applying automated contour detection.
Jamil Z; Tearney G; Bruining N; Sihan K; van Soest G; Ligthart J; van Domburg R; Bouma B; Regar E
Int J Cardiovasc Imaging; 2013 Jan; 29(1):39-51. PubMed ID: 22639296
[TBL] [Abstract][Full Text] [Related]
3. Comparison of longitudinal geometric measurement in human coronary arteries between frequency-domain optical coherence tomography and intravascular ultrasound.
Liu Y; Shimamura K; Kubo T; Tanaka A; Kitabata H; Ino Y; Tanimoto T; Shiono Y; Orii M; Yamano T; Yamaguchi T; Hirata K; Imanishi T; Akasaka T
Int J Cardiovasc Imaging; 2014 Feb; 30(2):271-7. PubMed ID: 24272334
[TBL] [Abstract][Full Text] [Related]
4. Serial 5-Year Evaluation of Side Branches Jailed by Bioresorbable Vascular Scaffolds Using 3-Dimensional Optical Coherence Tomography: Insights From the ABSORB Cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Grundeken MJ; Nakatani S; Asano T; Sotomi Y; Foin N; Ng J; Okamura T; Wykrzykowska JJ; de Winter RJ; van Geuns RJ; Koolen J; Christiansen EH; Whitbourn R; McClean D; Smits P; Windecker S; Ormiston JA; Serruys PW
Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28893770
[TBL] [Abstract][Full Text] [Related]
5. OCT compared with IVUS in a coronary lesion assessment: the OPUS-CLASS study.
Kubo T; Akasaka T; Shite J; Suzuki T; Uemura S; Yu B; Kozuma K; Kitabata H; Shinke T; Habara M; Saito Y; Hou J; Suzuki N; Zhang S
JACC Cardiovasc Imaging; 2013 Oct; 6(10):1095-1104. PubMed ID: 24011777
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of coronary computed tomography angiography for bioresorbable scaffold luminal investigation: a comparison with optical coherence tomography.
Collet C; Sotomi Y; Cavalcante R; Asano T; Miyazaki Y; Tenekecioglu E; Kistlaar P; Zeng Y; Suwanasson P; de Winter RJ; Nieman K; Serruys PW; Onuma Y
Int J Cardiovasc Imaging; 2017 Mar; 33(3):431-439. PubMed ID: 27896495
[TBL] [Abstract][Full Text] [Related]
7. Major coronary evaginations following implantation of bioresorbable vascular scaffolds - Clinical and OCT characteristics.
Blachutzik F; Achenbach S; Marwan M; Röther J; Tröbs M; Schneider R; Nef H; Weissner M; Schlundt C
Cardiovasc Revasc Med; 2019 Jun; 20(6):485-491. PubMed ID: 30097188
[TBL] [Abstract][Full Text] [Related]
8. First in human evaluation of the vascular biocompatibility and biomechanical performance of a novel ultra high molecular weight amorphous PLLA bioresorbable scaffold in the absence of anti-proliferative drugs: Two-year imaging results in humans.
Moncada M; Delgado JA; Colombo A; Gasior P; Ramzipoor K; Estrada A; Lee C; Dokko D; Granada JF
Catheter Cardiovasc Interv; 2018 Sep; 92(3):E246-E253. PubMed ID: 29243353
[TBL] [Abstract][Full Text] [Related]
9. Coronary calcification as a mechanism of plaque/media shrinkage in vessels treated with bioresorbable vascular scaffold: A multimodality intracoronary imaging study.
Zeng Y; Cavalcante R; Collet C; Tenekecioglu E; Sotomi Y; Miyazaki Y; Katagiri Y; Asano T; Abdelghani M; Nie S; Bourantas CV; Bruining N; Onuma Y; Serruys PW
Atherosclerosis; 2018 Feb; 269():6-13. PubMed ID: 29247976
[TBL] [Abstract][Full Text] [Related]
10. Frequency-domain optical coherence tomography assessment of unprotected left main coronary artery disease-a comparison with intravascular ultrasound.
Fujino Y; Bezerra HG; Attizzani GF; Wang W; Yamamoto H; Chamié D; Kanaya T; Mehanna E; Tahara S; Nakamura S; Costa MA
Catheter Cardiovasc Interv; 2013 Sep; 82(3):E173-83. PubMed ID: 23359350
[TBL] [Abstract][Full Text] [Related]
11. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
[TBL] [Abstract][Full Text] [Related]
12. Long-term invasive follow-up of bioresorbable vascular scaffold: Optical Coherence Tomography assessment of jailed side branches.
Paradies V; Smits PC; Vachojannis GJ; Royaards KJ; Wassing J; van der Ent M
Cardiovasc Revasc Med; 2018 Apr; 19(3 Pt A):279-285. PubMed ID: 29066339
[TBL] [Abstract][Full Text] [Related]
13. In-vitro and in-vivo imaging of coronary artery stents with Heartbeat OCT.
Cecchetti L; Wang T; Hoogendoorn A; Witberg KT; Ligthart JMR; Daemen J; van Beusekom HMM; Pfeiffer T; Huber RA; Wentzel JJ; van der Steen AFW; van Soest G
Int J Cardiovasc Imaging; 2020 Jun; 36(6):1021-1029. PubMed ID: 32112229
[TBL] [Abstract][Full Text] [Related]
14. Comparison of contrast media and low-molecular-weight dextran for frequency-domain optical coherence tomography.
Ozaki Y; Kitabata H; Tsujioka H; Hosokawa S; Kashiwagi M; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Takarada S; Kubo T; Kimura K; Tanaka A; Hirata K; Mizukoshi M; Imanishi T; Akasaka T
Circ J; 2012; 76(4):922-7. PubMed ID: 22301848
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of coronary Fourier domain optical coherence tomography: quantitative analysis of in vivo stented coronary arteries using three different software packages.
Okamura T; Gonzalo N; Gutiérrez-Chico JL; Serruys PW; Bruining N; de Winter S; Dijkstra J; Commossaris KH; van Geuns RJ; van Soest G; Ligthart J; Regar E
EuroIntervention; 2010 Aug; 6(3):371-9. PubMed ID: 20884417
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Arterial Remodeling After Bioresorbable Scaffold Implantation 4-Year Follow-up of Quantitative Coronary Angiography, Histology and Optical Coherence Tomography.
Chen D; Dong Z; Xi Y; Chen C; Zhang S; Zeng S; Bi Y; Wu T; Xiao J
Cardiovasc Eng Technol; 2020 Dec; 11(6):636-645. PubMed ID: 33108646
[TBL] [Abstract][Full Text] [Related]
17. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
[TBL] [Abstract][Full Text] [Related]
18. Serial 2-dimensional and 3-dimensional optical coherence tomography assessment of overhanging struts of drug-eluting absorbable metal scaffold: "DREAMS" for jailed side branch?
Muramatsu T; García-García HM; Serruys PW; Waksman R; Verheye S;
JACC Cardiovasc Interv; 2014 May; 7(5):575-6. PubMed ID: 24852807
[No Abstract] [Full Text] [Related]
19. Variability in quantitative and qualitative analysis of intravascular ultrasound and frequency domain optical coherence tomography.
Abnousi F; Waseda K; Kume T; Otake H; Kawarada O; Yong CM; Fitzgerald PJ; Honda Y; Yeung AC; Fearon WF
Catheter Cardiovasc Interv; 2013 Sep; 82(3):E192-9. PubMed ID: 23412754
[TBL] [Abstract][Full Text] [Related]
20. Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice.
Farooq V; Serruys PW; Heo JH; Gogas BD; Onuma Y; Perkins LE; Diletti R; Radu MD; Räber L; Bourantas CV; Zhang Y; van Remortel E; Pawar R; Rapoza RJ; Powers JC; van Beusekom HM; Garcìa-Garcìa HM; Virmani R
JACC Cardiovasc Interv; 2013 May; 6(5):523-32. PubMed ID: 23702016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
